APRICUS BIOSCIENCES, INC. Intellectual Property Contracts & Agreements
8 Contracts & Agreements
- License Agreements (8 contracts)
- License Agreement, dated as of November 24, 2021, by and between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited (Filed With SEC on November 24, 2021)
- Amendment to License Agreement, dated as of February 8, 2019, by and among Ligand Pharmaceuticals Incorporated, Neurogen Corporation, CyDex Pharmaceuticals, Inc., and Seelos... (Filed With SEC on March 17, 2020)
- Amended and Restated Exclusive License Agreement, dated August 29, 2019, by and between Seelos Therapeutics, Inc. and Stuart Weg, MD (Filed With SEC on November 7, 2019)
- License Agreement, dated September 21, 2016, by and among Seelos Therapeutics, Inc., Ligand Pharmaceuticals Incorporated, Neurogen Corporation and CyDex Pharmaceuticals (Filed With SEC on August 31, 2018)
- LICENSE AGREEMENT (Filed With SEC on March 8, 2017)
- LICENSE AGREEMENT AND AMENDMENT by and between WARNER CHILCOTT COMPANY, LLC (SUCCESSOR-IN-INTEREST TO WARNER CHILCOTT COMPANY, INC.) and NEXMED (U.S.A.), INC. Dated as of... (Filed With SEC on November 5, 2015)
- LICENSE AGREEMENT byand between FORENDO PHARMA LTD. and NEXMED (U.S.A.),INC., a wholly owned subsidiary of APRICUS BIOSCIENCES, INC. October 17, 2014 (Filed With SEC on October 20, 2014)
- LICENSE AGREEMENT (Filed With SEC on March 12, 2008)
